Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−28.1869 USD
−47.72 M USD
27.51 M USD
1.21 M
About Telesis Bio, Inc.
Sector
CEO
Eric Esser
Website
Headquarters
San Diego
Founded
2011
FIGI
BBG0118LR0M7
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TBIO is 0.6500 USD — it has decreased by −19.02% in the past 24 hours. Watch Telesis Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Telesis Bio, Inc. stocks are traded under the ticker TBIO.
TBIO stock has fallen by −25.53% compared to the previous week, the month change is a −57.76% fall, over the last year Telesis Bio, Inc. has showed a −99.37% decrease.
TBIO reached its all-time high on Jun 30, 2021 with the price of 8,326.8000 USD, and its all-time low was 0.8889 USD and was reached on Nov 11, 2024. View more price dynamics on TBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TBIO stock is 10.55% volatile and has beta coefficient of 0.65. Track Telesis Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Telesis Bio, Inc. there?
Today Telesis Bio, Inc. has the market capitalization of 1.26 M, it has decreased by −3.49% over the last week.
Yes, you can track Telesis Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Telesis Bio, Inc. is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
TBIO net income for the last quarter is −6.64 M USD, while the quarter before that showed −12.59 M USD of net income which accounts for 47.22% change. Track more Telesis Bio, Inc. financial stats to get the full picture.
No, TBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 27, 2024, the company has 147.00 employees. See our rating of the largest employees — is Telesis Bio, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Telesis Bio, Inc. EBITDA is −26.31 M USD, and current EBITDA margin is −112.86%. See more stats in Telesis Bio, Inc. financial statements.
Like other stocks, TBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Telesis Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Telesis Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Telesis Bio, Inc. stock shows the sell signal. See more of Telesis Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.